Coumarins as modulators of autophagy and PI3K/mTOR signaling: implications for next-generation cancer therapies
Yasser Fakri Mustafa · 2026
Read Coumarins as modulators of autophagy and PI3K/mTOR signaling: implications for next-generation cancer therapies by Yasser Fakri Mustafa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13627908.txt.
Description
Writing in 2026, Yasser Fakri Mustafa reviews coumarins, a family of natural and lab-made compounds, as possible tools against cancer. His focus is two systems inside cancer cells: autophagy, the process by which cells break down and recycle their own parts, and the PI3K/mTOR signaling pathway, which drives cell growth.
Mustafa gathered preclinical studies from major databases, keeping only work on cell or animal cancer models. The evidence shows coumarins can switch autophagy up or down depending on context, often by acting on PI3K/mTOR signaling, and that this affects whether cancer cells survive, die, or resist chemotherapy. He concludes that better drug design and patient selection are needed before such compounds reach the clinic.
Catalog record
| CREATOR | Yasser Fakri Mustafa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42374 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |